Courvoisier’s sign is a painless, enlarged gallbladder detected during a physical exam in a jaundiced patient, and its presence classically suggests that the bile duct is blocked by a tumor rather than a gallstone. The observation dates to 1890 and has been a staple of clinical teaching ever since, though its reliability in modern practice is more nuanced than the textbooks let on.
Where the Observation Came From
Swiss surgeon Ludwig Georg Courvoisier published a treatise in 1890 describing 187 cases of common bile duct obstruction. He noticed a pattern: when a gallstone caused the blockage, the gallbladder was rarely distended, but when something else caused the blockage, such as a tumor, the gallbladder tended to swell noticeably.1PubMed. Courvoisier’s gallbladder: law or sign? That observation was formalized into what generations of medical students have learned as “Courvoisier’s law,” though it is more accurately called a sign, since it is a clinical finding rather than an inviolable rule. The distinction matters because, as we’ll see, the sign has real exceptions.
Why Gallstones Shrink the Gallbladder and Tumors Enlarge It
The logic behind Courvoisier’s sign comes down to how the gallbladder wall responds to repeated versus gradual injury. When a person has gallstones, those stones tend to cause recurrent bouts of inflammation and infection over months or years. Each episode leaves behind a little more scar tissue. Over time, the gallbladder wall becomes fibrotic, thickened, and stiff. If a stone eventually lodges in the common bile duct and blocks bile flow, the gallbladder can’t stretch to accommodate the backed-up bile because it has already lost its elasticity. It stays small and shrunken, and a doctor pressing on the abdomen won’t feel it.
Tumors work differently. A cancer growing in the head of the pancreas, the ampulla of Vater, or the bile duct itself typically causes a slow, progressive obstruction. The gallbladder in these patients has never been subjected to the repeated inflammatory insults that stones produce, so the wall is still soft and compliant. As bile backs up behind the growing tumor, the gallbladder gradually distends like a balloon filling with water. Eventually it becomes large enough to feel through the abdominal wall, and the patient develops jaundice from the accumulating bilirubin. Research supports this framework: patients with dilated gallbladders from malignant obstruction show higher ductal pressures and more prolonged jaundice, consistent with chronic back-pressure being the driving force behind the distension.2PubMed. Pathogenesis of the “Courvoisier gallbladder”
The distinction rests on the gallbladder’s history, not the nature of the obstruction itself. A healthy, unscarred gallbladder will distend regardless of what’s blocking the duct, while a fibrotic one won’t. That insight is both the sign’s strength and the source of most of its exceptions.
Which Cancers Typically Produce the Sign
Cancer of the head of the pancreas is the most common malignancy associated with Courvoisier’s sign. The head of the pancreas sits right next to the common bile duct, so even a modestly sized tumor there can compress or invade the duct and obstruct bile flow. Because pancreatic cancer often grows silently for months before producing symptoms, the obstruction is gradual, giving the gallbladder time to dilate steadily.
Ampullary cancer, which arises where the bile duct and pancreatic duct empty into the small intestine, produces the sign in much the same way. A reported case of ampullary adenocarcinoma demonstrated both Courvoisier’s sign on physical exam and a “double duct sign” on imaging, meaning both the bile duct and the pancreatic duct were dilated behind the obstruction.3PubMed Central. Simultaneous Courvoisier’s and double duct signs Cholangiocarcinoma, a cancer that arises from the bile duct lining itself, can also cause the sign when it occurs in the distal (lower) portion of the duct. Tumors higher up in the biliary tree, near the liver, are less likely to produce a palpable gallbladder because the obstruction is above the point where the gallbladder connects to the system.
A painless, palpable gallbladder is encountered most often in pancreatic head cancer, and it can also appear with both benign and malignant growths at the ampulla of Vater.4Saudi Journal of Gastroenterology. Assessment of Courvoisier’s law Less commonly, metastatic disease from other organs that compresses the distal bile duct can produce the same picture.
How Reliable Is the Sign in Practice
The answer depends on what you’re asking the sign to do. If you’re asking whether a palpable, painless gallbladder in a jaundiced patient should raise suspicion for cancer, the answer is yes, strongly. If you’re asking whether the sign can definitively distinguish malignant from benign obstruction by itself, the evidence is mixed.
One ultrasound-based study measured actual gallbladder volumes in patients with dilated common bile ducts and found something surprising: the mean gallbladder volume was essentially the same in malignant and benign obstruction groups, roughly 93 ml versus 87 ml. The researchers concluded that gallbladder volume alone may not reliably differentiate the nature of the obstruction, and that what really determines gallbladder size is the degree of blockage combined with whether the gallbladder wall is fibrotic.5PubMed. Gallbladder volume in patients with common hepatic duct dilatation. An evaluation of Courvoisier’s sign using ultrasonography In other words, the sign works best as a shorthand for the gallbladder’s scarring history, not as a direct cancer detector.
However, a more recent study using MRI-based imaging of the biliary system found a statistically significant difference in mean gallbladder volume between patients with bile duct stones and those with non-stone causes of obstruction.6PubMed. Does Courvoisier’s sign stand the test of time? The same study also confirmed a significant volume difference between obstructive and non-obstructive groups overall. So the underlying principle, that gallbladders in malignant obstruction tend to be larger than those in stone-related obstruction, does hold up statistically across larger datasets, even if the overlap between groups means you can’t rely on it alone.
The practical takeaway: Courvoisier’s sign is a useful red flag, not a diagnosis. It shifts the probability toward malignancy enough to warrant urgent imaging, but it doesn’t replace a CT scan or biopsy.
When the Sign Misleads
Courvoisier originally framed his observation carefully, but over the decades it hardened into something closer to a binary rule in clinical teaching. In reality, there are several situations where the sign leads you astray in both directions.
False positives, where the gallbladder is palpable but the cause is benign, occur in a few scenarios. Chronic pancreatitis can occasionally cause enough fibrosis and stricturing of the distal bile duct to obstruct it slowly, mimicking the gradual compression seen with tumors. Because the gallbladder itself hasn’t been damaged by stones in these patients, it distends. Benign tumors or growths at the ampulla of Vater can also produce a painless, palpable gallbladder with jaundice.7Saudi Journal of Gastroenterology. Assessment of Courvoisier’s law Parasitic infections of the bile ducts, while uncommon in Western countries, represent another benign cause of obstruction that can produce gallbladder distension.
False negatives, where cancer is present but the gallbladder doesn’t enlarge, happen more often than students expect. If a patient happens to have both gallstones and a pancreatic tumor, the gallbladder may be too fibrotic to distend despite the malignant obstruction. Gallstones are common enough in the general population that this overlap isn’t rare. Additionally, tumors that invade or compress the cystic duct, which connects the gallbladder to the main bile duct, can prevent the gallbladder from filling even though it would otherwise be capable of distending. And in obese patients, even a significantly enlarged gallbladder may not be palpable on physical exam simply because it’s hidden beneath layers of tissue.
These exceptions explain why researchers and clinicians have debated for over a century whether to call Courvoisier’s observation a “law,” a “sign,” or a “tendency.” The term “sign” has largely won out in modern usage because it acknowledges the clinical usefulness of the finding without implying that it’s always true.
What the Sign Suggests About How Advanced a Cancer Is
There’s an interesting wrinkle to Courvoisier’s sign that doesn’t get much attention outside oncology circles. In patients with exocrine pancreatic cancer, the presence of cholestatic signs, the cluster of symptoms caused by bile duct blockage including jaundice, pale stools, dark urine, and itching, actually correlates with less advanced disease, not more. A study of pancreatic cancer patients found a clear trend: the more cholestatic signs a patient had at presentation, the more likely the tumor was to be localized rather than metastatic.8PubMed. Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage
This seems counterintuitive until you think about tumor geography. A cancer in the head of the pancreas blocks the bile duct early, when the tumor is still relatively small and confined. The patient notices jaundice and seeks medical attention. By contrast, cancers in the body or tail of the pancreas sit farther from the bile duct and can grow much larger, often spreading to distant organs before they produce any symptoms at all. By the time those patients show up, the disease is frequently advanced. So a patient presenting with Courvoisier’s sign and jaundice may paradoxically have a better chance of having a surgically resectable tumor than a pancreatic cancer patient who presents without jaundice.
This doesn’t make the prognosis good in absolute terms; pancreatic cancer remains one of the deadliest malignancies. But it does mean that the sign, while alarming, can sometimes be the reason a cancer is caught early enough for treatment to be attempted.
The Sign in an Era of Advanced Imaging
A reasonable question is whether Courvoisier’s sign matters when clinicians now have CT scans, MRI, endoscopic ultrasound, and other tools that can directly visualize the bile duct and whatever is blocking it. The sign was described in 1890, after all, when physical examination and exploratory surgery were the primary diagnostic methods.
The sign still has a role, though it’s different from what Courvoisier envisioned. In well-resourced healthcare settings, its main value is as a trigger for urgent workup. A primary care physician or emergency doctor who feels a painless, distended gallbladder in a jaundiced patient knows to order imaging quickly rather than managing the jaundice conservatively. The sign accelerates the diagnostic pathway even though the diagnosis will ultimately rest on imaging and tissue sampling.
In settings where advanced imaging isn’t immediately available, the sign carries more diagnostic weight. A palpable gallbladder combined with painless jaundice in a resource-limited clinic can guide decisions about referral and the urgency of transfer to a center with imaging and surgical capabilities. Physical examination findings remain essential clinical tools when technology is not at hand, and Courvoisier’s sign is among the more useful of those findings because the malignancies it points toward benefit from early surgical evaluation.
Modern imaging has also refined our understanding of why the sign works and when it fails. The MRI study that measured gallbladder volumes confirmed that the volumetric difference between stone-related and non-stone obstruction is real and statistically significant, validating the underlying observation with technology Courvoisier never had.9PubMed. Does Courvoisier’s sign stand the test of time? At the same time, the ultrasound study showing overlapping volumes between groups illustrates why palpation alone can’t make the distinction reliably.10PubMed. Gallbladder volume in patients with common hepatic duct dilatation. An evaluation of Courvoisier’s sign using ultrasonography The sign has survived 130-plus years of scrutiny not because it’s infallible, but because the mechanism behind it, a fibrotic gallbladder can’t stretch while a healthy one can, is fundamentally sound.
The “Law” Versus “Sign” Naming Debate
You’ll encounter Courvoisier’s observation described as a “law,” a “sign,” and occasionally as the “Courvoisier gallbladder” in different textbooks and papers.11PubMed. Courvoisier’s gallbladder: law or sign? The terminology isn’t just academic pedantry; it shapes how trainees think about the finding and, more importantly, how rigidly they apply it.
Calling it a “law” implies universality and invites a dangerous binary: palpable gallbladder means cancer, non-palpable means stones. That framing leads to the missed diagnoses described earlier, the patient with both stones and a tumor whose gallbladder doesn’t distend, or the patient with chronic pancreatitis whose gallbladder distends but who doesn’t have cancer. Calling it a “sign” is more honest. Signs are clinical observations that raise or lower the probability of a diagnosis; they are not deterministic. A positive Courvoisier’s sign increases the likelihood of malignant obstruction enough to change clinical management, but a negative one does not rule it out.
Some educators have pushed for calling it the “Courvoisier gallbladder” to sidestep the law-versus-sign debate entirely and focus attention on the physical finding itself: a distended, non-tender gallbladder in a jaundiced patient. The emphasis then falls on what to do when you find it, namely get imaging and a surgical opinion, rather than on whether to treat the finding as a reliable diagnostic rule. Whatever you call it, the core message for clinicians hasn’t changed since 1890: a painlessly swollen gallbladder in a jaundiced patient deserves urgent investigation for malignancy, and not finding one doesn’t mean you can relax.